Pages that link to "Q46825217"
Jump to navigation
Jump to search
The following pages link to FK614, a novel peroxisome proliferator-activated receptor gamma modulator, induces differential transactivation through a unique ligand-specific interaction with transcriptional coactivators (Q46825217):
Displaying 17 items.
- PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1 (Q24633440) (← links)
- Nuclear receptors and their selective pharmacologic modulators (Q26825692) (← links)
- Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats (Q28567397) (← links)
- Novel PPARγ partial agonists with weak activity and no cytotoxicity; identified by a simple PPARγ ligand screening system (Q33935032) (← links)
- The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis (Q34623928) (← links)
- Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer (Q34646050) (← links)
- HNF4α antagonists discovered by a high-throughput screen for modulators of the human insulin promoter (Q36249040) (← links)
- Transcriptional Regulation by Nuclear Corepressors and PGC-1α: Implications for Mitochondrial Quality Control and Insulin Sensitivity (Q36470524) (← links)
- Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of type 2 diabetes and atherosclerosis (Q36580568) (← links)
- A Role for the PPARgamma in Cancer Therapy. (Q36691611) (← links)
- Selective Modulators of PPAR-gamma Activity: Molecular Aspects Related to Obesity and Side-Effects (Q36772301) (← links)
- Discovery and development of selective PPAR gamma modulators as safe and effective antidiabetic agents. (Q37724195) (← links)
- PPARγ ligands and their therapeutic applications: a patent review (2008 - 2014). (Q38270503) (← links)
- Human pregnane X receptor is activated by dibenzazepine carbamate-based inhibitors of constitutive androstane receptor. (Q38910106) (← links)
- Urate transporter inhibitor lesinurad is a selective peroxisome proliferator-activated receptor gamma modulator (sPPARγM) in vitro (Q58756051) (← links)
- Importance of the Proximity and Orientation of Ligand-Linkage to the Design of Cinnamate-GW9662 Hybrid Compounds as Covalent PPARγ Agonists. (Q64952056) (← links)
- Molecular tuning of farnesoid X receptor partial agonism (Q91564601) (← links)